RECURSION PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.12 USD | +3.57% |
|
+10.48% | -17.65% |
| Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
| Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 9.090 | 15.52 | 15.47 |
| Spread/Res. | -10.67% | -47.68% | -47.51% |
| Spread/Supp. | +10.48% | +59.53% | +53.79% |
| Support | 7.350 | 5.090 | 5.280 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- RXRX Stock
- Charts Recursion Pharmaceuticals, Inc.
